The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes
Abstract
Type 2 diabetes is a pandemic disease with an incidence that has risen steadily over recent decades. Experimental evidence in animals has demonstrated that intestinal bypass surgery of the upper small intestine, particularly the duodenum, has an important role in glucose homoeostasis. Furthermore, Roux-en-Y bypass performed as bariatric surgery has shown to correct hyperglycaemia from the first postoperative days in obese diabetic patients. Therefore, on the basis of these considerations, duodenal mucosal resurfacing was studied in type 2 diabetes patients as a minimally invasive procedure that could offer an alternative treatment for these patients. Further studies, and particularly large controlled trials, are needed to determine the place of this procedure in the treatment of type 2 diabetes as well as other metabolic diseases such as non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some endoscopic and orally delivered devices have been approved by the FDA for treatment of obesity, including hydrogel capsules,786 intragastric balloon systems,787–788 a transpyloric shuttle that blocks gastric emptying,789 and gastric aspiration therapy that evacuates partial gastric contents following meals via a variation of a percutaneous endoscopic gastrostomy tube.790”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [789]
In the citing paper
“The intragastric balloon and transpyloric shuttle trials included some persons with T2D, but numbers were inadequate to assess safety and efficacy in those with T2D.787–789”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [789]
Citations
Cites
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Rubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G., Castagneto, M., & Marescaux, J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000224726.61448.1b · Cited by 928
Rubino, F., & Marescaux, J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000102989.54824.fc · Cited by 617
Rajagopalan, H., Cherrington, A. D., Thompson, C. C., Kaplan, L. M., Rubino, F., Mingrone, G., Becerra, P., Rodriguez, P., Vignolo, P., Caplan, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0383 · Cited by 216
Ferrannini, E., & Mingrone, G. (2009) · Diabetes Care · doi:10.2337/dc08-1762 · Cited by 194
Klein, S., Fabbrini, E., Patterson, B. W., Polonsky, K. S., Schiavon, C. A., Correa, J. L., Salles, J. E. N., WAJCHENBERG, B. L., & COHEN, R. V. (2012) · Obesity · doi:10.1038/oby.2011.377 · Cited by 69
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Haidry, R. J., van Baar, A. C., Galvao Neto, M. P., Rajagopalan, H., Caplan, J., Levin, P. S., Bergman, J. J., Rodriguez, L., Deviere, J., & Thompson, C. C. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.03.024 · Cited by 66
van Baar, A. C. G., Deviere, J. M. E., Hopkins, D., Crenier, L., Holleman, F., Neto, M. G., Becerra, P., Vignolo, P., Grunert, L. R., Mingrone, G., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109194 · Cited by 45
Self-citationKong, Y., Yang, H., Nie, R., Zhang, X., Zhang, H., & Nian, X. (2025) · European journal of medical research · doi:10.1186/s40001-025-02738-6 · Cited by 44
Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy
Král, J., Machytka, E., Horká, V., Selucká, J., Doleček, F., Špičák, J., Kovarova, V., Haluzík, M., & Bužga, M. (2021) · Nutrients · doi:10.3390/nu13124268 · Cited by 24
Metadata
- Authors
- Hadefi, A., Huberty, V., Lemmers, A., Arvanitakis, M., Maggs, D., Costamagna, G., & Devière, J.
- Affiliations
- Université Libre de Bruxelles (BE)
- Fractyl (United States) (US)
- Agostino Gemelli University Polyclinic (IT)
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 36
- Issue
- 4
- Pages
- 322-324
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2801537818
- Cited by
- 26
- References
- 6
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 8 · 2019: 3 · 2018: 1
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- Division of Materials Research
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Keywords
- type 2 diabetes, duodenal mucosal resurfacing, endoscopic mucosal resection, duodenal bypass, glucose homeostasis, hyperglycemia, bariatric surgery, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, minimally invasive treatment
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Duodenum, Endoscopy, Humans, Intestinal Mucosa, Male, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes. https://app.cochat.ai/papers/10.1159/000487078
- The paper
- Hadefi, A., Huberty, V., Lemmers, A., Arvanitakis, M., Maggs, D., Costamagna, G., & Devière, J. (2018). Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes. Digestive Diseases. https://doi.org/10.1159/000487078
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.